Employees: 11-50
Investment Type: Venture Capital
Portfolio 47
| Date | Name | Website | Total Raised | Location |
| - | Guoke-Heng... | heng-tai.com.cn | - | China, Bei... |
| - | Coherent B... | coherentbio.com | - | - |
| - | Vivace The... | vivacetherapeutics.com | $105M | United Sta... |
| - | Gloria Bio... | gloriabio.com | - | China |
| - | IDEAYA Bio... | ideayabio.com | $190M | - |
| - | MYZH | yideb.com | - | China, Bei... |
| - | Syros Phar... | syros.com | $123M | United Sta... |
| - | BeiGene | beigene.com | $75M | - |
| - | Realton Me... | realton.com.cn | - | - |
| - | Yikon Geno... | yikongenomics.com | - | China |
Show more
Mentions in press and media 2
| Date | Title | Description |
| 13.11.2018 | Kymera Therapeutics Announces $65 Million Series B | Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to create breakthrough medicines for patients, announced today that it has completed a $65 million Series B financing. The financing will support the ... |
| 31.07.2018 | Fresh out of 6 Dimensions' incubator, Curon launches with $150M and backing from Boyu, Temasek | The latest mega-round in the China biotech scene features some of the hottest VCs — and a pretty mysterious startup. Paul Song Curon Biopharmaceuticals has reaped $150 million in a Series A round that pulled in 6 Dimensions... |